CSC Financial said the medical-device sector recorded four consecutive quarters of positive growth through Q2 2026 and posted, for the first time in four years, a quarter of YoY growth in net profit attributable to the parent, indicating earnings recovery. 2025 profit declines were mainly driven by IVD centralized procurement, medical-service price adjustments, and one-off impairment charges and FX losses at some low-value consumables firms. The firm expects the industry to enter a new virtuous

CSC Financial said the medical-device sector recorded four consecutive quarters of positive growth through Q2 2026 and posted, for the first time in four years, a quarter of YoY growth in net profit attributable to the parent, indicating earnings recovery. 2025 profit declines were mainly driven by IVD centralized procurement, medical-service price adjustments, and one-off impairment charges and FX losses at some low-value consumables firms. The firm expects the industry to enter a new virtuous cycle as procurement effects clear, innovative products move into commercialization, and domestic manufacturers accelerate overseas expansion.